Electronic cigarettes containing nicotine increase endothelial and platelet derived extracellular vesicles in healthy volunteers.
Individual Clinical
Safety
Adverse Effects
Mobarrez (2020)
Impact of e-cigarettes on colonic mucosa and the role of recovery: involvement of oxidative and inflammatory pathway.
Individual Clinical
Safety
Adverse Effects
Mohammed (2021)
E-liquid exposure induces bladder cancer cells to release extracellular vesicles that promote non-malignant urothelial cell transformation.
Individual Clinical
Safety
Adverse Effects
Molony (2023)
association Between Electronic Cigarette Use and Levels of high-Sensitivity C-Reactive Protein and Uric acid.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Moon (2020)
high school students’ use of flavored e-cigarette e-liquids for appetite control and weight loss.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Morean (2020)
Estimating Fluid Consumption Volumes in Electronic Cigarette Use.
Individual Clinical
User Topography
Morgan (2020)
Vaping preferences of individuals who vaporise dry herb cannabis, cannabis liquids and cannabis concentrates.
Individual Clinical
User Topography
Morgan (2022)
Effects of E-Cigarette Flavoring Chemicals on human Macrophages and Bronchial Epithelial Cells.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Morris (2021)
Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to mybluTM electronic nicotine delivery systems (ENDS).
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Morris (2022)
E-cigarette flavored pods induce inflammation, epithelial barrier dysfunction, and DNa damage in lung epithelial cells and monocytes.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Muthumalage (2019)